PDLIM4 drives gastric cancer malignant progression and cisplatin resistance by inhibiting HSP70 ubiquitination and degradation via competitive interaction with STUB1.
Saved in:
| Title: | PDLIM4 drives gastric cancer malignant progression and cisplatin resistance by inhibiting HSP70 ubiquitination and degradation via competitive interaction with STUB1. |
|---|---|
| Authors: | Zhu, Chao1 (AUTHOR), Chen, Meng2,3 (AUTHOR), Fan, Linwei1 (AUTHOR), Wang, Yu1 (AUTHOR), Liu, Mengwei1 (AUTHOR), Kang, Guiyu1 (AUTHOR), Yin, Fang1 (AUTHOR), Tang, Hong1 (AUTHOR), He, Yun1 (AUTHOR), Zhang, Sifan1 (AUTHOR), Zeng, Linda1 (AUTHOR), Liu, Wei1 (AUTHOR) ndyfy05702@ncu.edu.cn, Yu, Kuai1 (AUTHOR) yukuai1949@foxmail.com, Le, Aiping1 (AUTHOR) ndyfy00973@ncu.edu.cn |
| Source: | Journal of Nanobiotechnology. 10/11/2025, Vol. 23 Issue 1, p1-25. 25p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14773155 |
|---|---|
| DOI: | 10.1186/s12951-025-03720-4 |
